Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4628 USD | +1.71% | -2.28% | -68.30% |
05-06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
05-06 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
End-of-day quotes
Sector Biopharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
14.75M | - | - | - | - | - | |
90.02B | ||||||
39.15B | ||||||
31.71B | ||||||
26.47B | ||||||
14.34B |